These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 14669614

  • 1. [Intravenous thrombolytic therapy in myocardial infarction (review)].
    Staroverov II.
    Ter Arkh; 2003; 75(10):80-3. PubMed ID: 14669614
    [No Abstract] [Full Text] [Related]

  • 2. What should a new thrombolytic bring us?
    Verheugt F.
    Int J Clin Pract Suppl; 1998 Nov; 99():3-5. PubMed ID: 10344033
    [No Abstract] [Full Text] [Related]

  • 3. [Bolus fibrinolysis in acute myocardial infarction].
    Zeymer U.
    Dtsch Med Wochenschr; 2002 Oct 04; 127(40):2083-6. PubMed ID: 12373644
    [No Abstract] [Full Text] [Related]

  • 4. [Thrombolysis in acute myocardial infarct].
    Heintzen MP, Michel CJ, Strauer BE.
    Internist (Berl); 1996 Jun 04; 37(6):585-96. PubMed ID: 8767991
    [No Abstract] [Full Text] [Related]

  • 5. Acute myocardial infarction: treatment with thrombolytic therapy.
    Topol EJ.
    Cardiol Clin; 1989 Nov 04; 7(4):827-36. PubMed ID: 2688884
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute myocardial infarction. A guide for North Carolina doctors.
    Williams ML, O'Meara JJ, Tate DA, Simpson RJ.
    N C Med J; 1995 Aug 04; 56(8):390-7. PubMed ID: 7566193
    [No Abstract] [Full Text] [Related]

  • 8. The effects of combined thrombolytic and platelet inhibitor therapy on myocardial and microvascular perfusion.
    de Lemos J.
    Md Med; 2001 Aug 04; Suppl():88-9. PubMed ID: 11434069
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Thrombolytic therapy of myocardial infarct. Status after GISSI-2 and ISIS-3].
    Gulba DC, Claus G.
    Internist (Berl); 1992 Apr 04; 33(4):206-15. PubMed ID: 1612844
    [No Abstract] [Full Text] [Related]

  • 12. The number needed to harm: is it too optimistic?
    Mancini GB, Schulzer M.
    Can J Cardiol; 2004 Nov 04; 20(13):1375; author reply 1376. PubMed ID: 15612137
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety profile of thrombolytic drugs.
    Maggioni AP, Fresco C.
    Arq Bras Cardiol; 1995 Jul 04; 65(1):87-90. PubMed ID: 8546604
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. How have trials of thrombolytics influenced clinical management of patients with acute myocardial infarction.
    Marder VJ.
    Thromb Haemost; 1997 Jul 04; 78(1):548-52. PubMed ID: 9198213
    [No Abstract] [Full Text] [Related]

  • 19. Thrombolytic therapy for acute myocardial infarction.
    Meister FL, Stringer KA, Spinler SA, Gonzalez E, Talbert RL, Weiner B, Guerrero RM, Smith R.
    Pharmacotherapy; 1998 Jul 04; 18(4):686-98. PubMed ID: 9692643
    [Abstract] [Full Text] [Related]

  • 20. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A, Iriarte Sotés P, Fernández González CJ, Garrote Freire A, González Tutor J.
    An Med Interna; 2003 Mar 04; 20(3):163-4. PubMed ID: 12756909
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.